[A clinical study on pulmonary tissue uptake of flomoxef]

Jpn J Antibiot. 1991 Jan;44(1):22-34.
[Article in Japanese]

Abstract

Based on the results of a study on pulmonary tissue uptake of flomoxef (FMOX), a new antibiotic agent, in 45 patients undergoing thoracotomy, the following conclusions were drawn: 1. Immediately preoperative 1 hour-drug infusion of 1 g FMOX led to maximum serum concentration (averaging 42.4 micrograms/ml) 1 hour later, with a half-life of its beta phase of 1.26 hours. 2. Normal lung (alveolar) tissue concentration was Cmax 17.98 micrograms/g with its ratios to serum peak value being 31.8, 27.1, 22.2, 9.4, 5.9 and 5.0% at 1, 2, 3, 4, 5 and 6 hours later, respectively. 3. Bronchiolar tissue concentration was Cmax 31.91 micrograms/g, with its ratios to serum peak value being 27.8, 19.3 and 10.1% at 2, 3 and 4 hours later, respectively, indicating its good bronchiolar intra-tissue transition. The above results suggested the usefulness of FMOX for both the treatment of respiratory infections and the prevention of postoperative infections.

Publication types

  • English Abstract

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Bronchi / metabolism
  • Cephalosporins / pharmacokinetics*
  • Cephalosporins / therapeutic use
  • Female
  • Half-Life
  • Humans
  • Infusions, Intravenous
  • Lung / metabolism*
  • Lung Neoplasms / surgery
  • Male
  • Middle Aged
  • Postoperative Complications / prevention & control
  • Premedication
  • Pulmonary Alveoli / metabolism
  • Respiratory Tract Infections / drug therapy
  • Respiratory Tract Infections / metabolism
  • Thoracotomy

Substances

  • Cephalosporins
  • flomoxef